Ceragenix to Present Urinary Catheter Data at European Conference
23. April 2008 08:19 ET
|
Ceragenix Pharmaceuticals
DENVER -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the "Company"), a biopharmaceutical and medical device company focused on infectious disease and dermatology, today announced that it will be...
Ceragenix Receives $1.5 Million Milestone Payment
07. April 2008 08:27 ET
|
Ceragenix Pharmaceuticals
DENVER, Apr 07, 2008 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:GXP) (the "Company"), a biopharmaceutical and medical device company focused on infectious disease and dermatology, today announced that...
Ceragenix Enters into Agreement to License CSA-54 and other Ceragenin Compounds To Biopharmaceutical Company for HIV and STD Applications
25. März 2008 08:09 ET
|
Ceragenix Pharmaceuticals
DENVER--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the "Company"), a biopharmaceutical and medical device company focused on infectious disease and dermatology, today announced that it has entered...
Ceragenix Completes Patient Visit Phase of Clinical Trial Study to Compare Efficacy of EpiCeram(R) to Elidel(R)
13. März 2008 17:47 ET
|
Ceragenix Pharmaceuticals
DENVER--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the "Company"), a biopharmaceutical and medical device company focused on infectious disease and dermatology, today announced that it had...
Dr. Michael Niederman Joins Ceragenix Scientific Advisory Board
29. Januar 2008 09:10 ET
|
Ceragenix Pharmaceuticals
DENVER, Jan 29, 2008 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology today announced that Michael S. Niederman MD, FACP,...
Ceragenin(TM) Compound Demonstrates Potent Activity Against Multidrug Resistant Bacterial Strains of Pseudomonas
20. Dezember 2007 08:14 ET
|
Ceragenix Pharmaceuticals
DENVER--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology today announced that researchers at the Eugene Appelbaum College of...
Ceragenix and Dr. Reddy's Enter Into Distribution and Supply Agreement for EpiCeram(r)
19. November 2007 09:27 ET
|
Ceragenix Pharmaceuticals
DENVER--Ceragenix Pharmaceuticals, Inc. (OTCB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology today announced that it has entered into an exclusive distribution and...
Ceragenix Pharmaceuticals to Present at The Rodman and Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th
31. Oktober 2007 13:10 ET
|
Ceragenix Pharmaceuticals
DENVER -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology, today announced that Steven Porter, its Chairman and Chief Executive...
Results of Pre-Clinical Investigation of Ceragenix's Developmental Antibiotic to Prevent Sepsis Presented at International Scientific Meeting
22. Oktober 2007 08:37 ET
|
Ceragenix Pharmaceuticals
DENVER, Oct 22, 2007 -- Ceragenix Pharmaceuticals, Inc. (OTCB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology, today announced that researchers at the Johns Hopkins...
Results of Pre-Clinical Investigations of Ceragenix's Developmental Antibiotic to Be Presented at International Scientific Meeting on Infectious Diseases
18. September 2007 08:30 ET
|
Ceragenix Pharmaceuticals
DENVER, Sep 18, 2007 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology, today announced that five poster presentations on the...